SDEVStablecoin Development Corp同业对比
Stablecoin Development Corp 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SDEV本股 | $42M#8 | — | 0.3x#1 | 4.3x#5 | -6.4%#4 | -8632.9%#16 | -86.3%#3 | -495.7%#11 | -7.0%#1 | — | -89.6%#14 | 11.5%#1 |
| VBIO | $50M#1 | — | 11.8x#12 | 64.0x#9 | -33.7%#5 | -57.0%#10 | -1012.6%#7 | -209.1%#9 | — | — | -97.1%#15 | — |
| ELTX | $49M#2 | — | 6.2x#10 | 21.2x#7 | -91.9%#8 | 23.8%#4 | -1639.0%#9 | -498.6%#12 | — | — | -83.9%#12 | — |
| PDSB | $48M#3 | — | — | — | — | 8.3%#7 | — | — | -541.6%#6 | — | -26.1%#2 | — |
| HOWL | $47M#4 | — | 2.9x#9 | — | — | 13.7%#5 | — | -373.3%#10 | -229.9%#3 | — | -32.2%#4 | — |
| ANVS | $46M#5 | — | — | — | — | -17.3%#8 | — | — | — | — | -53.6%#7 | — |
| SCYX | $44M#6 | 15.9x#3 | 0.7x#3 | 2.2x#3 | 449.9%#1 | 59.6%#2 | -78.0%#2 | -12.9%#2 | — | 7#1 | -45.1%#6 | — |
| KAPA | $42M#7 | — | 10.1x#11 | — | — | -109.3%#13 | — | -130.0%#8 | — | — | -85.0%#13 | — |
| MCRB | $41M#9 | — | 1.2x#4 | 52.0x#8 | — | 4088.2%#1 | -11910.1%#10 | 16.5%#1 | -72.9%#2 | — | -76.7%#11 | — |
| VERU | $41M#10 | — | 1.4x#6 | 2.4x#4 | 3.6%#2 | 39.9%#3 | -146.6%#4 | -80.1%#5 | -399.3%#5 | — | -31.6%#3 | 0.0%#2 |
| KPTI | $41M#11 | — | — | 0.3x#1 | 0.6%#3 | -156.5%#14 | -62.1%#1 | — | — | — | -70.7%#10 | — |
| ELAB | $39M#12 | — | 2.3x#8 | 65.6x#10 | — | -24.0%#9 | -1304.4%#8 | -46.3%#4 | — | — | -99.7%#16 | — |
| CRVO | $39M#13 | 0.0x#1 | 1.7x#7 | 9.6x#6 | -58.9%#7 | -65.6%#12 | -706.2%#6 | -117.5%#7 | -5165.9%#7 | — | -67.4%#9 | — |
| ATNM | $38M#14 | 3.4x#2 | 1.2x#5 | 419.2x#11 | — | 11.4%#6 | -40274.4%#11 | -111.8%#6 | — | — | -25.9%#1 | — |
| CELU | $37M#15 | — | — | 1.4x#2 | -51.0%#6 | -58.4%#11 | -230.9%#5 | — | -398.1%#4 | — | -41.8%#5 | — |
| LITS | $36M#16 | — | 0.6x#2 | — | -100.0%#9 | -189.7%#15 | — | -28.1%#3 | — | — | -59.7%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议